InvestorsHub Logo
Followers 11
Posts 1237
Boards Moderated 0
Alias Born 03/03/2019

Re: None

Wednesday, 10/06/2021 1:27:28 AM

Wednesday, October 06, 2021 1:27:28 AM

Post# of 146240
Nanoviricides will have a cure, because their mechanism of action works with the simulated human receptors that they’re engineering their nanodrug-capsules with.

https://www.benzinga.com/node/23025282

https://www.biospace.com/article/strong-effectiveness-of-nanoviricides-drug-candidates-observed-in-an-animal-model-of-infection-by-an-ace2-using-human-coronavirus/

The animal tests proved that the simulated human receptors remained intact on the nano-capsules in animals. This absolutely guarantees that they will work in humans, also being the same geometry. The virus attaching to the simulated human receptors in animals, means that the virus will definitely attach to the engineered receptors in humans. Any overlap will be negated, because the nanoparticles will be accompanied and synergistically complimented with Remdesivir.

In addition, the level of plasma drug concentration increased and bioavailability was directly related with the same dose, because of the metabolic decrease. This means that smaller doses will have equal or greater effect, since they can calculate the plasma level concentration from subsequent dose ranges. This is amazing. And the virus doesn’t know the difference.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News